| Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. | 2024 | Medicine |
| Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. | 2024 | Diabetes/Metabolism Research and Reviews |
| Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus. | 2024 | Diabetes, Obesity & Metabolism |
| Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: a systematic review and meta-analysis of 16 RCTs. | 2023 | Medicine |
| Effect of glucagon-like peptide-1 receptor agonists administration during coronary artery bypass grafting: a systematic review and meta-analysis of randomized control trials. | 2023 | Future Cardiology |
| Comparison of efficacy and safety of commercially available fixed-ratio combinations of insulin degludec/liraglutide and insulin glargine/lixisenatide: a network meta-analysis. | 2023 | Canadian Journal of Diabetes |
| The effects of cardioprotective antidiabetic therapy on microbiota in patients with type 2 diabetes mellitus-a systematic review. | 2023 | International Journal of Molecular Sciences |
| Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: a systematic review and meta-analysis of 16 RCTs. | 2023 | Medicine |
| The impact of glucagon-like peptide-1 receptor agonist on the cardiovascular outcomes in patients with type 2 diabetes mellitus: a meta-analysis and systematic review. | 2023 | Cardiology Research |
| Comparative effectiveness of multiple different treatment regimens for nonalcoholic fatty liver disease with type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis of randomised controlled trials. | 2023 | BMC Medicine |
| Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review. | 2022 | Therapeutic Advances in Chronic Disease |
| Safety and efficacy of liraglutide on reducing visceral and ectopic fat in adults with or without type 2 diabetes mellitus: a systematic review and meta-analysis. | 2022 | Diabetes, Obesity, and Metabolism |
| Efficacy and safety of liraglutide and semaglutide on weight loss in people with obesity or overweight: a systematic review. | 2022 | Clinical Epidemiology |
| The effect of liraglutide on renal function in type 2 diabetes: a meta-analysis of randomized controlled studies. | 2022 | African Health Sciences |
| Efficacy of liraglutide in non-diabetic obese adults: a systematic review and meta-analysis of randomized controlled trials. | 2022 | Journal of Clinical Medicine |
| Medications for obesity management: effectiveness and value. | 2022 | ICER |
| Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: a systematic review and network meta-analysis. | 2022 | Frontiers in Endocrinology |
| The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: a systematic review and network meta-analysis. | 2022 | Contemporary Clinical Trials Communicatons |
| Effects of glucagon-like peptide-1 receptor agonist (GLP-1RA) on cardiac structure and function: a systematic review and meta-analysis of randomized-controlled trials. | 2022 | Cardiovascular Drugs and Therapy |
| The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation/atrial flutter in patients with type 2 diabetes mellitus/heart failure: a systematic review and meta-analysis. | 2022 | Journal of Thoracic Disease |
| Meta-analysis of seven heterogeneous studies on liraglutide add-on therapy in patients with type 2 diabetes mellitus treated with insulin. | 2022 | Diabetes & Metabolic Syndrome |
| Efficacy and safety of the new appetite suppressant, liraglutide: a meta-analysis of randomized controlled trials. | 2021 | Diabetes, Obesity and Metabolism |
| Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Pharmacological Research |
| Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. | 2021 | Heart Failure Reviews |
| GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials. | 2021 | Diabetes Research and Clinical Practice |
| Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: a network meta-analysis. | 2021 | Diabetes Research and Clinical Practice |
| Cardioprotective properties of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus patients: a systematic review. | 2021 | Diabetes and Metabolic Syndrome |
| Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Clinics and Research in Hepatology and Gastroenterology |
| Comparison of the effects of 10 GLP-1 RA and SGLT2 inhibitor interventions on cardiovascular, mortality, and kidney outcomes in type 2 diabetes: a network meta-analysis of large randomized trials. | 2021 | Primary Care Diabetes |
| Effect of liraglutide on cardiometabolic risk profile in people with coronary artery disease with or without Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Frontiers in Pharmacology |
| The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2021 | European Journal of Pharmacology |
| Comparative efficacy of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular events in type 2 diabetes: a network meta-analysis. | 2021 | Journal of Cardiovascular Pharmacology |
| Systematic review of glucagon-like peptide one receptor agonist liraglutide of subjects with heart failure with reduced left ventricular ejection fraction. | 2021 | Current Diabetes Reviews |
| Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis. | 2020 | Cardiovascular Diabetology |
| Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. | 2020 | Annals of Internal Medicine |
| Liraglutide reduces systolic blood pressure in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. | 2020 | Clinical and Experimental Hypertension |
| Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials. | 2020 | Nutrition, Metabolism, and Cardiovascular Diseases |
| Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies. | 2020 | Metabolism: Clinical and Experimental |
| Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map. | 2020 | The Lancet. Diabetes & Endocrinology |
| Analysis of the effect of liraglutide on glycemic variability in patients with type 2 diabetes. | 2020 | Endocrine Journal |
| Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials. | 2019 | BMC Endocrine Disorders |
| Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis. | 2019 | British Journal of Clinical Pharmacology |
| Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: a retrospective multicentre study and meta-analysis of observational studies. | 2019 | Diabetes, Obesity & Metabolism |
| Asian subpopulations may exhibit greater cardiovascular benefit from long-acting glucagon-like peptide 1 receptor agonists: a meta-analysis of cardiovascular outcome trials. | 2019 | Diabetes & Metabolism Journal |
| Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. | 2019 | Acta Diabetologica |
| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. | 2019 | The Lancet. Diabetes & Endocrinology |
| Orally administered semaglutide versus GLP-1 RAs in patients with type 2 diabetes previously receiving 1-2 oral antidiabetics: systematic review and network meta-analysis. | 2019 | Diabetes Therapy |
| Cardiovascular outcomes of liraglutide in patients with type 2 diabetes: a systematic review and meta-analysis. | 2019 | Medicine |
| Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis. | 2019 | Diabetes, Obesity & Metabolism |
